Agenus Inc. Profile Avatar - Palmy Investing

Agenus Inc.

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human a…

Biotechnology
US, Lexington [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Agenus Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of AGEN's Analysis
CIK: 1098972 CUSIP: 00847G705 ISIN: US00847G7051 LEI: - UEI: -
Secondary Listings
AGEN has no secondary listings inside our databases.